J&J shares down 1.3% premarket after Q4 revenue lags consensus
Yahoo! Finance
Johnson & Johnson shares slid 1.3% premarket Tuesday, after the consumer goods, pharmaceutical and medical device maker posted weaker-than-expected revenue for the fourth quarter. The company posted net income of $4.736 billion, or $1.77 a share, for the quarter, up from $1.738 billion, or 65 cents a share, in the year-earlier period. Adjusted per-share earnings came to $2.13, a penny ahead of the $2.12 FactSet consensus. Sales climbed 10.4% to $24.804 billion from $22.475 billion a year ago, be
Continue Reading